Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines.

by Clement A Meseda, Vajini Atukorale, Jordan Kuhn, Falko Schmeisser, Jerry P Weir
Published 2016-01-01

Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.

by Esmeralda Alvarado-Facundo, Russell Vassell, Falko Schmeisser, Jerry P Weir, Carol D Weiss, Wei Wang
Published 2016-01-01

Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.

by Falko Schmeisser, Anupama Vasudevan, Swati Verma, Wei Wang, Esmeralda Alvarado, Carol Weiss, Vajini Atukorale, Clement Meseda, Jerry P Weir
Published 2015-01-01

Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.

by Swati Verma, Jackeline Soto, Anupama Vasudevan, Falko Schmeisser, Esmeralda Alvarado-Facundo, Wei Wang, Carol D Weiss, Jerry P Weir
Published 2017-01-01

Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses

by Peter Radvak, Martina Kosikova, Yuan-Chia Kuo, Xing Li, Richard Garner, Falko Schmeisser, Ivan Kosik, Zhiping Ye, Jerry P. Weir, Jonathan W. Yewdell, Hang Xie
Published 2021-02-01

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.

by Wei Wang, Russell Vassell, Hyo Sook Song, Qiong Chen, Paul W Keller, Swati Verma, Esmeralda Alvarado-Facundo, Hongquan Wan, Falko Schmeisser, Clement A Meseda, Jerry P Weir, Carol D Weiss
Published 2019-01-01